Expert NetworkExpert InterviewKPTI

Slingshot members are talking to an expert! The topic is:

A Third Look: Discussing Karyopharm's Subgroup Analysis SIENDO Study in Patients with TP53 Wild Type Endometrial Cancer for Selinexor as Maintenance Therapy

Executed on:May 11, 2023 3:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: University of Leuven
  • Emeritus Professor with Scientific assignment at the Catholic University of Leuven and consultant at the University Hospitals Leuven
  • Main areas of clinical and translational research focus on gynecological cancer. He has authored more than 1020 original full papers in peer-reviewed journals. 
  • Currently Editor of the European Journal of Cancer
 

Interview Goal

This conversation will focus on the potential of Karyopharm's  selinexor as a maintenance therapy for TP53 WT endometrial cancer patients.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.